The global transient ischemic attack market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period (2021-2027). The rising pervasiveness of cardiovascular diseases is one of the prime factors affecting and driving the market. According to the World Health Organisation (WHO) around 17.9 million people across the globe die due to cardiovascular diseases (CVD) every year. Moreover, Blood pressure is one of the important factors resulting in the increasing risk of transient ischemic attack and ischemic stroke due to their strong associations, high prevalence, and the possibility for intervention in the people.
Browse the full report description of "Global Transient Ischemic Attack Market Research By Diagnosis (Carotid Ultrasonography, CT Scan and CT Angiography Scan, MRI Scan and MR Angiography, Echocardiography, Electrocardiogram and Other), By Treatment (Medication, Surgery, and Angioplasty), and By End-User (Hospital & Clinics, Research Institutes, and Diagnostic Centers) Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/transient-ischemic-attack-market
Further, to gain on the opportunity key players operating in the global transient ischemic attack market had been adopting an expansion strategy. For instance, in July 2020, Daiichi Sankyo Co. Ltd., had put forward the results of Phase 3 of its prasugrel antiplatelet agent, with regards to patients suffered from thrombotic stroke. This study was conducted in order to check the efficacy and safety in 234 thrombotic stroke patients for recurrence of ischemic stroke.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By Diagnosis
o By Treatment
o By End-Users
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Transient Ischemic Attack Market
By Diagnosis
• Carotid Ultrasonography
• CT Scan and CT Angiography Scan
• MRI Scan and MR Angiography
• Echocardiography
• Electrocardiogram
• Other
By Treatment
• Medication
• Surgery
• Angioplasty
By End-Users
• Hospital & Clinics
• Research Institutes
• Diagnostic Centers
Global Transient Ischemic Attack Market by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/transient-ischemic-attack-market